DEF: Adtalem Global Education Exceeds FY25 Targets, Fuels Growth

Adtalem Global Education reported exceptional FY25 financial and operational results, surpassing growth targets and strengthening its position as a leading healthcare educator.

Summary

• Revenue reached $1.79 billion in FY25, representing 12.9% year-over-year growth, more than doubling the 2023 investor day targets of 4-6%.
• Adjusted earnings per share (EPS) grew 33.1% to $6.67, significantly exceeding the 2023 investor day targets of 10-15%.
• Total enrollment surpassed 91,000 students, demonstrating over 10% average quarterly growth.
• Graduated 29,000 students in FY25, with approximately 90% entering healthcare professions.
• Chamberlain University achieved its tenth consecutive quarter of growth, reaching a record of over 40,000 students.
• Walden University delivered eight consecutive quarters of accelerating growth, surpassing 48,000 students and pre-pandemic levels.
• The Medical and Veterinary segment maintained excellence with over 5,000 enrolled students.
• Adjusted EBITDA margin expanded by 190 basis points to 25.7%, surpassing the investor day expansion target of 100 basis points.
• Operating cash flow from continuing operations increased by $45 million to $334 million in FY25.
• Returned $211 million to shareholders through share repurchases, completing the prior $300 million program and announcing a new $150 million program through May 2028.
• Reduced outstanding letters of credit with the U.S. Department of Education from 20% to 10% of Title IV receipts.
• The FY23-FY25 Revenue Performance Share Units (PSUs) achieved 200% of target, while the FY23-FY25 EBITDA margin PSUs achieved 86% of target, resulting in a combined weighted payout of 143%.
• Supplemental Growth with Purpose (GwP) PSU awards resulted in a 200% payout for revenue metrics and 171% for adjusted EBITDA margin, for an overall weighted payout of 186%.

Sentiment

Score: 9

Explanation: The filing presents an overwhelmingly positive outlook, highlighting exceptional financial and operational performance that significantly exceeded ambitious targets. Strong shareholder returns, strategic advancements, and a clear vision for future growth contribute to a highly favorable sentiment.

Positives

• Achieved robust revenue growth of 12.9% to $1.79 billion, significantly exceeding investor day targets.
• Delivered exceptional adjusted EPS growth of 33.1% to $6.67, far surpassing investor day targets.
• Reported total enrollment exceeding 91,000 students, with consistent double-digit quarterly growth across institutions.
• Successfully graduated 29,000 students in FY25, with 90% entering high-demand healthcare professions.
• Chamberlain University achieved a record 40,000+ students and its tenth consecutive quarter of growth.
• Walden University surpassed pre-pandemic enrollment levels with over 48,000 students and eight consecutive quarters of accelerating growth.
• Expanded adjusted EBITDA margin by 190 basis points to 25.7%, exceeding the 100 basis points investor day target.
• Generated strong operating cash flow of $334 million, an increase of $45 million from the prior year.
• Returned substantial capital to shareholders through $211 million in share repurchases and announced a new $150 million program.
• Strengthened the balance sheet with a healthy 0.8x adjusted net leverage and reduced debt servicing costs by 75 basis points.
• Improved regulatory standing by reducing outstanding letters of credit with the U.S. Department of Education from 20% to 10% of Title IV receipts.
• Achieved a five-year cumulative total shareholder return of +308%, significantly outperforming the S&P 500 (+116%), Russell 2000 (+61%), and its peer group average (+113%).
• Medical and Veterinary segment achieved a 95% first-time residency attainment rate for its medical schools and Ross University School of Veterinary Medicine ranked 1st nationally for selective internships and residencies.
• Launched the Aspiring Nurse Program in partnership with SSM Health, projected to graduate and employ over 400 nurses annually.
• Walden University was certified as a B-Corporation, recognizing its commitment to balancing profit with purpose.
• Implemented ground-breaking student-facing investments, including AI-powered learning technologies and the Believe and Achieve scholarship program, benefiting over 50,000 students.

Negatives

• FY23-FY25 EBITDA margin PSUs achieved 86% of target, indicating a slight underperformance against the established goal.
• The Medical/Veterinary segment's adjusted operating income component for the Management Incentive Plan (MIP) payout was 63.9% of target, reflecting underperformance in this specific metric.
• Scott Liles's overall MIP payout was 93% of target, indicating a slight underperformance against his overall goals.

Risks

• Regulatory and policy trends in the higher education sector, including those from the U.S. Department of Education, pose ongoing challenges.
• Technology, cybersecurity, and information risks require continuous management and oversight to safeguard sensitive data.
• The U.S. faces acute workforce shortages across healthcare professions, which, while an opportunity, also represents a broader industry challenge.
• Higher education faces important questions about accessibility, career relevance, and value, requiring continuous innovation to remain competitive.
• Disclosure of segment-level financial targets (e.g., Walden and Med/Vet revenue and operating income) is considered competitively sensitive and could result in competitive harm.
• Ongoing litigation costs and settlements related to divestitures are a recurring expense, as noted in non-GAAP adjustments.

Future Outlook

Adtalem Global Education aspires to become a systemically important, highly integrated partner for healthcare employers and policymakers, crucial for building talent pipelines in the U.S. healthcare infrastructure. The company plans to further align executive compensation with performance in FY26, with the CEO's equity awards comprising 100% PSUs and other NEOs' awards comprising 70% PSUs. Continued capital deployment into high-return growth opportunities and returning excess capital to shareholders are also key priorities, alongside scaling innovative programs like the Aspiring Nurse Program nationwide.

Management Comments

• "Fiscal 2025 stands as both a proof point and an inflection point for Adtalem—validating our thesis while positioning us for our next phase of growth as a vital component of healthcare infrastructure."
• "Our integrated operating model delivered exceptional results that validated operational excellence as our primary vehicle for sustainable value creation."
• "Our sustained execution has earned us the right to seek a larger and more visible role in America's critical healthcare infrastructure."
• "We are not merely participants in healthcare education; we are positioned to play an increasingly vital role in ensuring America's healthcare system has the skilled professionals it needs to function effectively."
• "Our commitment remains unwavering: delivering outstanding student outcomes at scale while building the healthcare workforce America needs. We are not just growing a business—we are strengthening the foundation of our nation's healthcare system."

Industry Context

Adtalem operates within a U.S. healthcare landscape facing acute workforce shortages across all professions, positioning itself as a critical solution provider by preparing practice-ready graduates. In the broader higher education context, where accessibility, career relevance, and value are under scrutiny, Adtalem distinguishes itself by democratizing education and expanding access to healthcare careers for non-traditional students through technology-enabled and competency-based programs. Healthcare employers increasingly rely on Adtalem to meet staffing needs, particularly in underserved markets, making the company an innovator in educational delivery and a vital partner in workforce development.

Comparison to Industry Standards

• Adtalem's five-year cumulative total shareholder return of +308% significantly outperformed the S&P 500 (+116%), the Russell 2000 (+61%), and its self-determined peer group average (+113%) as of June 30, 2025.
• The peer group used for comparison includes American Public Education, Inc. (APEI), Graham Holdings Company (GHC), Grand Canyon Education, Inc. (LOPE), Laureate Education, Inc. (LAUR), Perdoceo Education Corporation (PRDO), and Strategic Education, Inc. (STRA).
• Chamberlain University is recognized as the nation's largest nursing school.
• The Medical and Veterinary segment collectively ranks at the top nationally for the number of students matched into U.S. veterinary and medical residency programs.
• Ross University School of Veterinary Medicine ranked 1st among institutions whose graduates matched into selective internships and residencies.
• Walden University and Chamberlain University were recognized as 'Opportunity Colleges and Universities' in the 2025 Student Access and Earnings Classification by the Carnegie Foundation and American Council on Education.

Management Changes

Corporate Governance

Legal Proceedings

• The company incurred expenses from ongoing litigation costs and settlements related to divestitures, as reflected in adjustments to non-GAAP financial measures.

Related Party Transactions

• There were no transactions in FY25 that required approval under company policies and procedures or disclosure as required by SEC rules.

Stakeholder Impact

• Shareholders: Experienced exceptional financial performance, significant shareholder returns (+308% over five years), and benefited from share repurchases and a strengthened balance sheet.
• Students: Gained expanded access to high-quality healthcare education, benefited from enhanced student experiences through AI-powered learning and personalized enrollment, and achieved strong career outcomes, including high residency attainment rates.
• Employees: Offered opportunities to contribute to a mission-driven organization, with compensation programs designed to attract, retain, and motivate high-performing talent.
• Healthcare Employers: Provided with a critical supply of practice-ready graduates, addressing acute workforce shortages, and benefited from strategic partnerships like the Aspiring Nurse Program.
• Communities and Policymakers: Contributed to strengthening the U.S. healthcare infrastructure by preparing professionals for underserved areas, and recognized for educational quality and student empowerment as 'Opportunity Colleges and Universities' and a B-Corporation.

Next Steps

• Hold the Annual Meeting of Shareholders on November 12, 2025, to elect directors, ratify PricewaterhouseCoopers LLP as the independent registered public accounting firm, and conduct an advisory vote on named executive officer compensation.
• Continue deploying capital to high-return growth opportunities and return excess capital to shareholders through the new $150 million share repurchase program, authorized through May 2028.
• Further align executive compensation with performance in FY26 by structuring the CEO's equity awards as 100% PSUs and other NEOs' awards as 70% PSUs.
• Scale the Aspiring Nurse Program nationwide, creating a replicable framework for addressing critical workforce needs.
• Maintain ongoing engagement and transparent dialogue with shareholders on business updates, strategic outlook, compensation, and global impact.

Key Dates

Recommendation

Adtalem Global Education delivered outstanding financial and operational results in FY25, significantly exceeding its ambitious targets for revenue, adjusted EPS, and adjusted EBITDA margin. The company's 5-year cumulative total shareholder return of +308% demonstrates superior value creation compared to major market indices and its peer group. The 'Growth with Purpose' strategy is proving highly effective, driving enrollment growth and strengthening its position as a leader in healthcare education. Strategic capital allocation, including share repurchases and debt reduction, further enhances shareholder value. With a clear vision for addressing critical healthcare workforce shortages and a commitment to educational excellence, Adtalem is well-positioned for sustained growth and continued outperformance, making it a compelling 'strong buy' for seasoned investors.

Keywords

Healthcare education, Adtalem Global Education, ATGE, SEC filing, Financial results, Enrollment growth, Executive compensation, Corporate governance, Risk management, Strategic growth, Walden University, Chamberlain University, Medical education, Veterinary medicine, Nursing education, Proxy statement, Shareholder return, EBITDA, EPS